2 weeks ago
Godavari Biorefineries secures European patent for anti-cancer drug composition
A company in India called Godavari Biorefineries got a special award called a patent from Europe.
A patent is like a certificate that says, 'We invented this, and no one else can copy it without permission.'
The invention is a medicine recipe that helps fight cancer.
The recipe mixes special cancer-fighting ingredients with another ingredient that helps the body absorb them better.
This makes the medicine work better and be more useful.
The medicine could be used to treat breast cancer and prostate cancer.
It can be taken by mouth, which is easier for patients.
The company's scientists worked hard to make the medicine easier for the body to use.
The company's leaders say this is an important step in their research journey.
The company usually makes ethanol and bio-based chemicals, but now it is also working on healthcare solutions.
Godavari Biorefineries Limited secured a product and process patent from the European Patent Office for a pharmaceutical composition combining novel anti-cancer compounds with a solubilising agent.
The composition is designed to enhance the solubility and bioavailability of the active compounds, improving their therapeutic potential.
The patent has significant applications in treating cancers, including breast and prostate cancers, through oral administration.
The patent adds to Godavari Biorefineries Limited's oncology-focused intellectual property portfolio.
Godavari Biorefineries is the flagship company of the Somaiya Group, one of India's largest producers of ethanol and manufacturers of bio-based speciality chemicals.
- Who
- Godavari Biorefineries Limited, the flagship company of the Somaiya Group, led by Chairman and Managing Director Samir Somaiya and Executive Director Dr Sangeeta Srivastava.
- What
- Secured a product and process patent from the European Patent Office for a pharmaceutical composition combining novel anti-cancer compounds with a solubilising agent.
- Where
- Granted by the European Patent Office in Europe.
- When
- Announced in an article published on August 17, 2026.
- Why
- To enhance the solubility and bioavailability of anti-cancer compounds, improving their therapeutic potential for treating cancers including breast and prostate cancers.
Key facts
- Company
- Godavari Biorefineries Limited
- Patent Office
- European Patent Office
- Patent Type
- Product and process patent
- Composition
- Novel anti-cancer compounds with a solubilising agent
- Applications
- Treating cancers including breast and prostate cancers via oral administration
- Parent Group
- Somaiya Group
- Key Executives
- Samir Somaiya (Chairman and Managing Director), Dr Sangeeta Srivastava (Executive Director)
- Company Profile
- One of India's largest producers of ethanol and manufacturers of bio-based speciality chemicals
Quotes
Dr Sangeeta Srivastava
Executive Director, Godavari Biorefineries Limited
“In oncology research, identifying a promising compound is only one part of the challenge. How that compound is formulated can determine how effectively it can be developed for therapeutic use. Our research has focused on improving the solubility and bioavailability of these compounds, and the grant of this European patent is an important recognition of that work.”
thehindubusinessline.com
“Our investments in R&D are enabling us to build capabilities in areas where science and technology can address meaningful societal needs. This European patent is an important milestone in that journey, strengthening our intellectual property and opening possibilities for developing solutions with potential applications in healthcare.”
thehindubusinessline.com
Sources
Related news
Nanded University Secures Indian Patent for Tuberculosis Nano-Drug Delivery
India’s Smart Cancer Drug RK-251 Targets Tumor Cells
FDA Approves Rasonque for Advanced Pancreatic Cancer Treatment
Dr. JRK's Research & Pharmaceuticals Expands Global Healthcare Presence
